Stocks · News reference

Needham Maintains Buy on Bicycle Therapeutics, Lowers Price Target to $14

Jul 30, 2026, 7:15 PMBenzinga Newsdesk

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Keep reading

SEC EDGARAug 20, 2026, 8:05 PMSEC EDGAR
8-K filing — BICYCLE THERAPEUTICS PLC (BCYC)
Filed: 2026-08-20 AccNo: 0001104659-26-099221 Size: 241 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgar
BCYC
BenzingaJul 30, 2026, 11:56 AMBenzinga Newsdesk
Bicycle Therapeutics Q2 EPS $(0.72) Misses $(0.59) Estimate, Sales $629.000K Miss $4.221M Estimate
Read original at benzinga
BCYC